All lobbying filings

CROSSROADS STRATEGIES, LLC

CROSSROADS STRATEGIES, LLC filed a Q1 report for HALEON US HOLDINGS LLC on April 20, 2025, reporting $50,000 in lobbying income.

Lobbying for HALEON US HOLDINGS LLC · consumer health care company

All filings by CROSSROADS STRATEGIES, LLC · Everything HALEON US HOLDINGS LLC has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 20, 2025

Income

$50,000

What the client paid this registrant for the period.

Client based in

New Jersey

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Health Issues

Issues related to healthcare and payment for over-the-counter drugs; General education of over-the-counter switches, including reauthorization of the Over-the-Counter Monograph Drug User Fee Act and policies impacting a Nonprescription Drug Product with an Additional Condition for Nonprescription Use.

Taxation/Internal Revenue Code

Issues related to coverage of over-the-counter products with FSAs and HSAs; H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (P.L.119-4).

Budget/Appropriations

Policies impacting access to over-the-counter products; H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (P.L.119-4).

Bills named in this filing 1

H.R. 1968
Full-Year Continuing Appropriations and Extensions Act, 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.